The association between mineralocorticoid receptor antagonist use and diabetes occurrence and progression: A systematic review and meta‐analysis
Spironolactone use is associated with modest but statistically significant improvements in HbA1c and glucose levels compared to placebo, suggesting a potential glycaemic benefit.
Authors
- Lasin Özbek
- Peter Rossing
- MUSTAFA GULDAN
- Ibrahim Gulmaliyev
- Aladin Rustamov
- Mehmet Kanbay
- Alberto Ortiz
Institutions
- Steno Diabetes Centers (DK)
- Koç University (TR)
- Hospital Universitario Fundación Jiménez Díaz (ES)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1002/bcp.70433
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00